Lord, Abbett & Co’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Lord, Abbett & Co's TWST Position: Q1 2026 in Review
Lord, Abbett & Co opened a new position in Twist Bioscience (TWST) in Q1 2026: 99,630 shares worth $4.73M. The stake represents 0.02% of the portfolio and ranks #464 among its holdings. This is a return to the name: Lord, Abbett & Co previously reported a position in TWST as recently as Q1 2025.
Lord, Abbett & Co first reported a position in TWST in Q2 2019 and has held it in 14 quarters since. The position peaked at $62.3M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Lord, Abbett & Co held 99,630 shares of Twist Bioscience worth $4.73M as of Q1 2026.
- Twist Bioscience was a new Lord, Abbett & Co position in Q1 2026.
- Twist Bioscience made up 0.02% of Lord, Abbett & Co's portfolio in Q1 2026, its #464 holding.
- Lord, Abbett & Co first reported a position in Twist Bioscience in Q2 2019 and has held it in 14 quarters since.
- Lord, Abbett & Co's Twist Bioscience position peaked at $62.3M in Q4 2020.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.